Mann steps aside as CEO of Mannkind

Mann, however, will continue to remain engaged in the company's activities in his new role as executive chairman of the company, which has a large manufacturing facility located in Danbury. Under Mann's tenure, the company developed and eventually received FDA approval earlier this year of Afrezza, a fast-acting inhalable form of insulin that some analysts say could revolutionize treatments for diabetics.



via Danbury Newswire http://ift.tt/1C4IUlP